Recent Updates
Recently added Catalysts
ESPR Positive Sentiment Score: 70/100

Esperion to Participate in Upcoming Jefferies London Healthcare Conference

Key Takeaway: Esperion (NASDAQ: ESPR) announced its participation in the 2024 Jefferies London Healthcare Conference, scheduled for November 19, 2024. The event will be available via a live webcast accessible on the company's investor and media section. A replay of the webcast will be available shortly after the event, archived for approximately 90 days for broader accessibility.

Market Sentiment Analysis

POSITIVE FACTORS

  • Esperion is actively participating in an important healthcare conference.
  • The company is enhancing its visibility to investors through a webcast.
  • The webcast will be archived for wider access over the next 90 days.

Full Press Release Details

ANN ARBOR, Mich., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 2024 Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 11:30 a.m. ET.
The live webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for approximately 90 days.
Esperion Therapeutics
Esperion Contact Information:

Frequently Asked Questions

When is Esperion participating in the Jefferies Conference?

Esperion will participate in the 2024 Jefferies London Healthcare Conference on November 19, 2024.

How can I access the live webcast?

The live webcast can be accessed on the investor and media section of the Esperion website.

Will there be a replay of the webcast?

Yes, the webcast replay will be available about two hours after the call.

How long will the replay be archived?

The webcast replay will be archived on Esperion's website for approximately 90 days.

What is Esperion's investor relations contact?

You can contact Esperion at investorrelations@esperion.com for inquiries.

Last updated: Nov 4, 2024